V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10324397 | 10071063 | null | null | null | 2013-06-13 | 2017-10-29 | Radium 223 | 02 | null | CARBOPLATIN + ETOPOSIDE | 101632972 |
| 10324889 | 10071065 | 1.68 | 73.1 | 03 | 2022-02-10 | 2022-02-10 | null | 02 | N | POMALIDOMIDE | 101262419 |
| 10325540 | 10071066 | 1.8 | 68.2 | Curative (C) | 2020-01-07 | 2020-01-25 | null | 02 | N | BORTEZOMIB + DARATUMUMAB | 100900869 |
| 10326909 | 10071069 | 1.75 | 71 | Palliative (P) | 2019-07-22 | 2019-07-22 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100048468 |
| 10329035 | 10071071 | 1.62 | 59 | null | 2019-06-16 | 2019-12-29 | CISPLATIN + VINORELBINE | 02 | null | CABOZANTINIB | 100904689 |
| 10329739 | 10071074 | 1.64 | 62.6 | Palliative (P) | null | 2022-04-20 | CETUXIMAB + IRINOTECAN + MDG | 99 | N | BORTEZOMIB + THALIDOMIDE | 100954058 |
| 10330398 | 10071076 | 1.59 | 78.8 | null | 2021-10-25 | 2022-01-06 | Methotrexate intrathecal | N | null | METHOTREXATE | 100291968 |
| 10330979 | 10071077 | 1.76 | 71.3 | Palliative (P) | null | 2020-11-18 | Cisplatin 7 day | 02 | N | CISPLATIN | 100452643 |
| 10331112 | 10071078 | null | 76.35 | null | 2019-02-06 | 2019-02-06 | VINORELBINE | 02 | null | CAPECITABINE + IRINOTECAN | 101041789 |
| 10331403 | 10071079 | null | 67.4 | 03 | null | 2021-02-17 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100152013 |
| 10332234 | 10071082 | 1.68 | 83 | 03 | null | 2022-04-20 | Melphalan IV High dose | 02 | N | MELPHALAN | 101818860 |
| 10332384 | 10071084 | 1.71 | 78 | null | null | 2021-05-04 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100402818 |
| 10332422 | 10071085 | 1.63 | 63 | Palliative (P) | 2018-09-08 | 2018-09-08 | CABOZANTINIB | 02 | N | CAPECITABINE + IRINOTECAN | 101626166 |
| 10333576 | 10071087 | 1.54 | 77.8 | Palliative (P) | 2018-09-07 | 2018-12-24 | Niraparib | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101130252 |
| 10333855 | 10071088 | 1.7 | 0 | Palliative (P) | null | 2018-11-28 | Bortezomib + Thalidomide +/- Dex | 2 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100221537 |
| 10334459 | 10071089 | 1.5 | 100.2 | null | 2020-10-02 | 2020-11-19 | Acalabrutinib | 02 | null | CABOZANTINIB | 100347002 |
| 10334840 | 10071090 | 1.59 | 68.25 | Neo-adjuvant (N) | 2017-07-28 | 2018-05-08 | Cisplatin + Radiotherapy | N | N | CAPECITABINE + IRINOTECAN | 101617369 |
| 10335799 | 10071092 | null | 92 | null | 2021-12-17 | 2022-02-28 | Busulfan Oral | 02 | null | ACALABRUTINIB | 100110642 |
| 10335969 | 10071093 | null | 83 | 03 | 2020-12-16 | 2020-12-21 | Cyclophosphamide High Dose | 02 | N | CYCLOPHOSPHAMIDE | 101325059 |
| 10336057 | 10071094 | 1.69 | 57.5 | 03 | 2022-01-20 | 2022-01-31 | null | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100151259 |
| 10336205 | 10071095 | 1.63 | 90 | null | 2020-10-25 | 2020-11-18 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101294257 |
| 10337202 | 10071098 | 1.62 | 58.8 | Palliative (P) | null | 2018-04-29 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100709955 |
| 10337954 | 10071099 | 1.78 | 60.6 | Palliative (P) | 2021-10-30 | 2021-10-31 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100774395 |
| 10342041 | 10071102 | 0 | 94.1 | null | 2020-06-06 | 2020-10-08 | Niraparib | 02 | null | DABRAFENIB | 100515927 |
| 10343942 | 10071103 | 1.7 | 58.4 | Palliative (P) | 2020-10-10 | 2020-10-20 | Cyclophosphamide Weekly PO | N | null | CYCLOPHOSPHAMIDE | 100348848 |
| 10346155 | 10071105 | 1.58 | 68.8 | Palliative (P) | 2019-09-06 | 2019-10-04 | Cetuximab 14 day | 02 | N | CABOZANTINIB | 101144118 |
| 10349266 | 10071107 | 1.75 | 63 | Adjuvant (A) | 2021-01-18 | 2021-02-01 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101278660 |
| 10354581 | 10071109 | 1.87 | null | null | 2019-10-03 | 2019-10-17 | Melphalan IV High dose | 02 | null | MELPHALAN | 100820369 |
| 10355560 | 10071110 | 1.58 | 67 | null | 2022-02-24 | 2022-03-31 | CYCLOPHOSPHAMIDE | 02 | null | CYCLOPHOSPHAMIDE | 101498072 |
| 10356446 | 10071111 | 1.78 | 63 | null | 2019-06-29 | 2021-10-06 | Cabazitaxel | 02 | null | CABAZITAXEL | 101175884 |
| 10358907 | 10071113 | 1.58 | 59.95 | null | 2019-08-28 | 2021-03-03 | GEMCITABINE | 02 | null | GEMCITABINE | 100331139 |
| 10359193 | 10071114 | 1.57 | 83.5 | Palliative (P) | 2022-01-23 | 2022-02-13 | Chlorambucil | null | N | CHLORAMBUCIL | 100567201 |
| 10364764 | 10071117 | 1.67 | 74.2 | null | 2018-03-12 | 2018-09-17 | DABRAFENIB | 02 | null | NIRAPARIB | 101416604 |
| 10365670 | 10071120 | null | 91.4 | 03 | 2021-11-11 | 2021-12-27 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CISPLATIN + GEMCITABINE | 101222193 |
| 10367828 | 10071122 | null | 53.7 | 03 | 2020-04-11 | 2020-04-29 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101414832 |
| 10368044 | 10071123 | 1.56 | null | null | 2019-12-20 | 2020-03-25 | Cabazitaxel | 02 | null | CABAZITAXEL | 100186007 |
| 10368801 | 10071124 | 1.5 | 59.1 | null | 2019-06-17 | 2019-06-17 | CETUXIMAB | null | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101799038 |
| 10369028 | 10071125 | 1.7 | 77.4 | null | 2020-05-05 | 2020-09-22 | AFATINIB | 02 | null | AFATINIB | 100358720 |
| 10369153 | 10071126 | 1.72 | 85 | Curative (C) | 2018-06-01 | 2018-06-01 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | NIRAPARIB | 100332133 |
| 10369910 | 10071129 | null | null | Palliative (P) | 2017-02-20 | 2017-03-26 | Cisplatin 7 day | null | N | CETUXIMAB | 101524358 |
| 10370593 | 10071130 | 1.67 | 102.5 | 03 | 2019-06-11 | 2019-06-27 | AFATINIB | 02 | N | AFATINIB | 101250125 |
| 10371607 | 10071131 | null | 86.15 | Palliative (P) | 2018-07-02 | 2019-07-02 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | CHLORAMBUCIL + OBINUTUZUMAB | 100704184 |
| 10371951 | 10071133 | 1.62 | 77.3 | null | 2019-10-26 | 2020-02-23 | CABOZANTINIB | 02 | null | FLUOROURACIL | 100237364 |
| 10372545 | 10071134 | null | 59.1 | Adjuvant (A) | 2019-04-15 | 2019-04-25 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101674853 |
| 10372614 | 10071135 | 1.95 | 76.95 | null | 2016-10-20 | 2016-10-20 | Melphalan IV High dose | 02 | null | MELPHALAN | 100242286 |
| 10372696 | 10071136 | 1.77 | 67.4 | 03 | null | 2019-03-14 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 100609012 |
| 10373066 | 10071137 | 1.74 | 0 | null | null | 2020-08-17 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100977109 |
| 10373856 | 10071138 | null | 120 | Palliative (P) | 2019-07-04 | 2019-07-08 | Niraparib | 02 | N | CISPLATIN + GEMCITABINE | 100381016 |
| 10374243 | 10071139 | 1.66 | 74.2 | Adjuvant (A) | null | 2020-01-24 | Palbociclib | 02 | N | PALBOCICLIB | 100520147 |
| 10374886 | 10071140 | 1.57 | 89.4 | Palliative (P) | 2021-06-12 | 2021-06-14 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101053096 |